European Cancer Congress 2013: Abstract Submission
This year ECC 2013 has seen a record 38 percent increase in the number of abstracts submitted in comparison to the Stockholm Congress in 2011. The largest number of submissions came from Japan, followed by the Netherlands, UK, Italy, Spain and the USA.
Abstract submission deadlines
|Regular abstracts||17 April 2013|
|Late-breaking abstracts||7 August 2013|
ECC 2013 abstracts news
With a record number of abstract submissions, the Congress will play a pivotal role in establishing standards for the future in Europe. Basic, translational research and drug development made up 23 percent of all submissions, clearly demonstrating the importance of basic and translational research to this meeting. This highlights the uniqueness of the Congress in bringing together scientists and clinicians to discuss the fundamentals of cancer, furthering the understanding and development of its diagnosis, treatment and care.
Increased numbers of radiotherapy, systemic therapy, surgery, pathology and radiology abstracts, demonstrates the true multidisciplinarity of the meeting. Gastrointestinal malignancies are proving to be the most popular tumour type, with 20 percent of all abstracts submitted covering colorectal and noncolorectal topics. This is closely followed by breast cancer, genitourinary malignancies, lung cancer and head and neck cancer. This year we saw a 64 percent rise in the submission of abstracts on gynaecological cancer compared to 2011, propelling gynaecological cancer into the Top Ten for abstract submission.
For more information about abstract submission, please contact Davi Kaur.